characteristics

Number (48 patients)

%

Age

(Mean ± SD)

56.8 ± 10.8

Median (range)

57 (29 - 75)

Sex

Male

33

68.8%

Female

15

31.2%

ECOG performance status

0

1

2.1%

1

28

58.3%

2

19

39.6%

Pathology

squamous cell carcinoma

18

37.5%

adenocarcinoma

18

37.5%

Others

12

25%

T Stage

1

4

8.3%

2

16

33.3%

3

20

41.7%

4

8

16.7%

N Stage

1

9

18.8%

2

19

39.6%

3

14

29.2%

4

6

12.5%

Response to chemotherapy

Partial

20

41.7%

Stationary

28

58.3%

Number of metastasis

1

3

6.3%

2

11

22.9%

3

19

39.6%

4

10

20.8%

5

5

10.4%

EGFR

Negative

15

31.3%

Positive

5

10.4%

Not applicable

28

58.3%

ALK

Negative

19

39.6%

Positive

1

2.1%

Not applicable

28

58.3%

CNS metastasis

Yes

11

22.9%

No

37

77.1%

Site of metastasis

Single organ

19

39.6%

Multiple organ

29

60.4%